112.35
+3.94(+3.63%)
Currency In USD
| Previous Close | 108.41 |
| Open | 108.91 |
| Day High | 114.66 |
| Day Low | 108.91 |
| 52-Week High | 139.13 |
| 52-Week Low | 72.21 |
| Volume | 822,370 |
| Average Volume | 652,601 |
| Market Cap | 5.53B |
| PE | -19.11 |
| EPS | -5.88 |
| Moving Average 50 Days | 106.82 |
| Moving Average 200 Days | 103.19 |
| Change | 3.94 |
If you invested $1000 in Axsome Therapeutics, Inc. (AXSM) since IPO date, it would be worth $12,854.69 as of July 10, 2025 at a share price of $112.35. Whereas If you bought $1000 worth of Axsome Therapeutics, Inc. (AXSM) shares 5 years ago, it would be worth $1,352.96 as of July 10, 2025 at a share price of $112.35.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4
GlobeNewswire Inc.
Yesterday at 11:00 AM GMT
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for
Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21
GlobeNewswire Inc.
Jul 07, 2025 11:00 AM GMT
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will host its Frontiers in Brain
Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month
GlobeNewswire Inc.
Jun 20, 2025 11:00 AM GMT
NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today is joining with the Alzheimer’s disease advocacy c